ES2157886T3 - Composiciones tensioactivas y procedimientos. - Google Patents

Composiciones tensioactivas y procedimientos.

Info

Publication number
ES2157886T3
ES2157886T3 ES90911834T ES90911834T ES2157886T3 ES 2157886 T3 ES2157886 T3 ES 2157886T3 ES 90911834 T ES90911834 T ES 90911834T ES 90911834 T ES90911834 T ES 90911834T ES 2157886 T3 ES2157886 T3 ES 2157886T3
Authority
ES
Spain
Prior art keywords
compositions
tensioactive
procedures
assay
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911834T
Other languages
English (en)
Inventor
Bradley J Benson
John H Frenz
Cynthia P Quan
Steven Shak
Kathleen A Shiffer
John T Stults
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Genentech Inc
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH, Genentech Inc filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Application granted granted Critical
Publication of ES2157886T3 publication Critical patent/ES2157886T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES SURFACTANTES ESTABLES PARA EL PULMON, ASI COMO METODOS PARA SU PREPARACION, MODIFICACION, FORMULACION, ENSAYO Y USO TERAPEUTICO.
ES90911834T 1989-07-11 1990-07-10 Composiciones tensioactivas y procedimientos. Expired - Lifetime ES2157886T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37868889A 1989-07-11 1989-07-11

Publications (1)

Publication Number Publication Date
ES2157886T3 true ES2157886T3 (es) 2001-09-01

Family

ID=23494139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911834T Expired - Lifetime ES2157886T3 (es) 1989-07-11 1990-07-10 Composiciones tensioactivas y procedimientos.

Country Status (8)

Country Link
EP (1) EP0482097B1 (es)
JP (1) JPH04506809A (es)
AT (1) ATE201880T1 (es)
AU (1) AU638474B2 (es)
DE (1) DE69033745T2 (es)
DK (1) DK0482097T3 (es)
ES (1) ES2157886T3 (es)
WO (1) WO1991000871A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
CZ292186B6 (cs) 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití
WO2000005585A1 (en) 1998-07-24 2000-02-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Determination of the hydrophobic pulmonary surfactant protein sp-c
WO2000023569A1 (en) * 1998-10-20 2000-04-27 Children's Hospital Medical Center Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
CA2383140C (en) 1999-09-24 2007-12-04 Kyorin Pharmaceutical Co., Ltd. Ppar.alpha. and ppar.gamma. inhibitors
WO2001039573A2 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von lungensurfactant zur behandlung von legionärskrankheit
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
NZ536796A (en) 2002-04-25 2007-03-30 Scripps Research Inst Treatment and prevention of pulmonary conditions comprising at least one lung surfactant polypeptide and at least one protease inhibitor, lipase inhibitor or an anti-oxidant
SE0203591D0 (sv) 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
CN101171514B (zh) 2005-05-11 2011-07-20 雅玛山酱油株式会社 肺表面活性蛋白的稳定化方法
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
NZ607358A (en) 2010-08-23 2015-04-24 Takeda Gmbh Humidified particles comprising a therapeutically active substance
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use

Also Published As

Publication number Publication date
ATE201880T1 (de) 2001-06-15
DE69033745D1 (de) 2001-07-12
AU638474B2 (en) 1993-07-01
EP0482097B1 (en) 2001-06-06
WO1991000871A1 (en) 1991-01-24
JPH04506809A (ja) 1992-11-26
DK0482097T3 (da) 2001-09-17
EP0482097A1 (en) 1992-04-29
DE69033745T2 (de) 2002-02-28
AU6066690A (en) 1991-02-06

Similar Documents

Publication Publication Date Title
ATE201880T1 (de) Oberflächenaktive zusammensetzungen und verfahren
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
FI972054A0 (fi) Immunogeenisiä koostumuksia
DK0386451T3 (da) Oxiderede diphenylheteroalkaner, fremgangsmåde til fremstilling heraf og anvendelsen af disse
CA2063273A1 (en) Surfactant compositions and methods
ES2148142T3 (es) Compuestos de 2-aril-5-(trifluorometil)-2-pirrolina y procedimiento para la fabricacion de insecticidas de 2-aril-1-(alcoximetil)-4-halo-5-(trifluorometil)pirrol.
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
PA8449301A1 (es) Composiciones farmaceuticas
SE8003433L (sv) Substituerade pyrido(1,2-a)pyrimidiner
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
DK351484A (da) Pyrazolo(3,4,5-kl)acridinforbindelser, deres fremstilling og anvendelse
IT1241396B (it) Composizioni tensioattive, loro preparazione e loro impiego come agenti antischiuma. (caso 150-5294)
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
ES2159002T3 (es) Glucuronil-arabinaratos, su procedimiento de obtencion y aplicaciones de los mismos.
SE8502865L (sv) Naftoxaziner, deras framstellning och anvendning
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
ES2051916T3 (es) Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros.
SE8503513L (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 482097

Country of ref document: ES